| |  Online-Ressource |
|---|
| Verfasst von: | Barben, Jürg [VerfasserIn]  |
|---|
| | Sommerburg, Olaf [VerfasserIn] |
|---|
| Titel: | The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe |
|---|
| Verf.angabe: | Jürg Barben, Carlo Castellani, Jeannette Dankert-Roelse, Silvia Gartner, Nataliya Kashirskaya, Barry Linnane, Sarah Mayell, Anne Munck, Dorota Sands, Olaf Sommerburg, Simon Pybus, Victoria Winters, Kevin W Southern |
|---|
| Jahr: | 2017 |
|---|
| Jahr des Originals: | 2016 |
|---|
| Umfang: | 7 S. |
|---|
| Teil: | volume:16 |
|---|
| | year:2017 |
|---|
| | number:2 |
|---|
| | pages:207-213 |
|---|
| | extent:7 |
|---|
| Fussnoten: | Available online 30 December 2016 ; Gesehen am 20.09.2018 |
|---|
| Titel Quelle: | Enthalten in: Journal of cystic fibrosis |
|---|
| Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 2002 |
|---|
| Jahr Quelle: | 2017 |
|---|
| Band/Heft Quelle: | 16(2017), 2, Seite 207-213 |
|---|
| ISSN Quelle: | 1873-5010 |
|---|
| Abstract: | Background: Newborn screening (NBS) for cystic fibrosis (CF) is a well-established public health strategy with international standards. The aim of this study was to provide an update on NBS for CF in Europe and assess performance against the standards. Methods: Questionnaires were sent to key workers in each European country. Results: In 2016, there were 17 national programmes, 4 countries with regional programmes and 25 countries not screening in Europe. All national programmes employed different protocols, with IRT-DNA the most common strategy. Five countries were not using DNA analysis. In addition, the processing and structure of programmes varied considerably. Most programmes were achieving the ECFS standards with respect to timeliness, but were less successful with respect to sensitivity and specificity. Conclusions: There has been a steady increase in national CF NBS programmes across Europe with variable strategies and outcomes that reflect the different approaches. |
|---|
| DOI: | doi:10.1016/j.jcf.2016.12.012 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: http://dx.doi.org/10.1016/j.jcf.2016.12.012 |
|---|
| | Volltext: http://www.sciencedirect.com/science/article/pii/S1569199316306816 |
|---|
| | DOI: https://doi.org/10.1016/j.jcf.2016.12.012 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Carriers |
|---|
| | CFSPID |
|---|
| | Cystic fibrosis |
|---|
| | IRT |
|---|
| | Newborn bloodspot screening |
|---|
| | PAP |
|---|
| K10plus-PPN: | 1581137710 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
¬The¬ expansion and performance of national newborn screening programmes for cystic fibrosis in Europe / Barben, Jürg [VerfasserIn]; 2017 (Online-Ressource)
